• Fund Type: SICAV
  • Objective: Health Care Sector
  • Asset Class: Equity
  • Geographic Focus: International

Credit Suisse Lux Biotechnology Equity Fund

+ Add to Watchlist

CR4A:GR

321.2100 EUR 5.4000 1.71%

As of 11:16:11 ET on 11/21/2014.

Snapshot for Credit Suisse Lux Biotechnology Equity Fund (CR4A)

Open: 315.9600 High - Low: 322.2200 - 315.9600 Primary Exchange: Berlin
Volume: 0 52-Week Range: 201.6000 - 329.1500 Beta vs NBI: 0.9504

ETF Chart for CR4A

No chart data available.
  • CR4A:GR 319.5100
  • 1D
  • 1M
  • 1Y
315.8100
Interactive CR4A Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for CR4A

Credit Suisse Lux Biotechnology Equity Fund is a SICAV incorporated in Luxembourg. The Fund is actively managed aiming to outperform the return of the NASDAQ Biotechnology TR benchmark. The Fund mainly invests in equity and equity-type securities of issuers engaged in the biotechnology industry.

Inception Date: 2001-11-06 Telephone: -
Managers: IRENE BEATRICE PUETTNER
Web Site: www.credit-suisse.com

Fundamentals for CR4A

NAV -
Assets (M) (on 2014-11-20) 217.3363
Shares out (M) 0.00
Market Cap (M) 0.00
% Premium -
Average 52-Week % Premium -
Fund Leveraged N

Dividends for CR4A

No dividends reported

Performance for CR4A

1-Month +10.02% 1-Year +46.89%
3-Month +20.42% 3-Year +50.35%
Year To Date +42.15% 5-Year +31.52%
Expense Ratio -

Top Fund Holdings for CR4A

Filing Date: 08/29/2014
Name Position Value % of Total
Gilead Sciences Inc 185,484 19,954,369 9.514%
Celgene Corp 175,276 16,654,726 7.941%
Amgen Inc 111,973 15,606,797 7.441%
Biogen Idec Inc 40,745 13,977,165 6.664%
Alexion Pharmaceuticals Inc 61,752 10,453,996 4.984%
Regeneron Pharmaceuticals Inc 27,000 9,464,040 4.512%
Vertex Pharmaceuticals Inc 94,000 8,795,580 4.194%
BioMarin Pharmaceutical Inc 114,444 8,150,702 3.886%
Incyte Corp 145,000 7,859,000 3.747%
Medivation Inc 80,000 7,300,800 3.481%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil